Position in ZYME
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$429,385
+$143,047 QoQ
Shares Held
17,148
+57.7% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZYME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026State of Wyoming holds $10,984,351 across 71 Biotechnology names. ZYME ranks #8 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDXG |
Mimedx Group, Inc.
|
163,115 | $644,304 | |
| 2 | ADMA |
Adma Biologics, Inc.
|
60,978 | $549,411 | |
| 3 | FTRE |
Fortrea Holdings Inc.
|
54,857 | $516,752 | |
| 4 | PBYI |
Puma Biotechnology, Inc.
|
75,808 | $484,413 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
7,258 | $469,084 | |
| 6 | ARQT |
Arcutis Biotherapeutics, Inc.
|
18,434 | $434,305 | |
| 7 | STOK |
Stoke Therapeutics, Inc.
|
13,262 | $431,810 | |
| 8 | ZYME |
Zymeworks Inc.
This page
|
17,148 | $429,385 |
All Filings in ZYME
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $429,385 | 17,148 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $286,338 | 10,875 | Shares | Sole | 2026-02-11 | |
| 2024-06-30 | $34,882 | 4,099 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $116,140 | 11,040 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $114,175 | 10,989 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $124,555 | 19,646 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||